These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Non-secreting form of IgD multiple myeloma]. Kraj M; Michalak T; Karpowicz E Nowotwory; 1984; 34(4):355-8. PubMed ID: 6443020 [No Abstract] [Full Text] [Related]
47. Evaluation of specific protein analysis in a non-teaching hospital laboratory. Salkie ML; McNeil EM Ann Clin Biochem; 1974 Jul; 11(4):112-9. PubMed ID: 4214469 [No Abstract] [Full Text] [Related]
48. Monoclonal IgD. A comparative study of 60 sera with IgD "M" component. Fine JM; Rivat C; Lambin P; Ropartz C Biomedicine; 1974 Mar; 21(3):119-25. PubMed ID: 4429767 [No Abstract] [Full Text] [Related]
49. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. Isobe T; Osserman EF N Engl J Med; 1974 Feb; 290(9):473-7. PubMed ID: 4204196 [No Abstract] [Full Text] [Related]
50. Plasmablastic IgM multiple myeloma with hypocellular bone marrow. Arter ZL; Miles D; Mignano S; Cordaro D; Roswarski J Ann Hematol; 2020 Apr; 99(4):895-896. PubMed ID: 32055929 [No Abstract] [Full Text] [Related]
51. The bone marrow in multiple myeloma: correlation of plasma cell ultrastructure and clinical state. Graham RC; Bernier GM Medicine (Baltimore); 1975 May; 54(3):225-43. PubMed ID: 167264 [TBL] [Abstract][Full Text] [Related]
52. [IgD myeloma with amyloidosis. Description of a case]. Sánchez Rodríguez A; Sánchez Martín S; González Macías J; García Marcos MA; Díez Jarilla JL; de Castro del Pozo S Rev Clin Esp; 1981 May; 161(3):187-91. PubMed ID: 7268128 [No Abstract] [Full Text] [Related]
53. Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Morris C; Iacobelli S; Gahrton G; van Biezen A; Drake M; Garderet L; Potter M; Schattenberg AV; Cornelissen JJ; Hamladji RM; Martelli M; Petersen E; Rovira M; Bandini G; Kroger N; de Witte T Biol Blood Marrow Transplant; 2015 Jun; 21(6):1054-8. PubMed ID: 25708221 [TBL] [Abstract][Full Text] [Related]
54. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma. Sarı M; Sarı S; Nalçacı M Turk J Haematol; 2017 Jun; 34(2):131-136. PubMed ID: 27795224 [TBL] [Abstract][Full Text] [Related]
55. [A case of IgD myeloma with markedly atypical myeloma cells resembling monocytes or lymphoreticular cells]. Himori T; Ujiie S; Sugawara N; Ikeno S; Saito T Rinsho Ketsueki; 1972 Dec; 13(6):996-1005. PubMed ID: 4567234 [No Abstract] [Full Text] [Related]
56. Diagnosis and management of multiple myeloma and related disorders. Kyle RA Prog Hematol; 1986; 14():257-82. PubMed ID: 2418463 [No Abstract] [Full Text] [Related]
57. [A case report of IgD myeloma]. Maachi M; Fellahi S; Golea G Ann Biol Clin (Paris); 2001; 59(6):758-60. PubMed ID: 11713022 [No Abstract] [Full Text] [Related]
58. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
59. [Immunoglobulin D lambda multiple myeloma: a case report]. Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885 [TBL] [Abstract][Full Text] [Related]
60. Controlled environment culture of bone marrow explants from human myeloma. Gailani S; McLimans WF; Mundy GR; Nussbaum A; Roholt O; Zeigel R Cancer Res; 1976 Apr; 36(4):1299-304. PubMed ID: 4220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]